Search results
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial
Morningstar· 4 days agoModerna and Merck said they saw positive results from a Phase 2b study evaluating mRNA-4157 in combination with Keytruda in patients with high-risk skin cancer< ...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 4 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 12 hours agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 4 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy ...
Gene-Targeted Immunotherapy Boosts Survival for Some Colon Cancer Patients
US News & World Report· 4 days agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more patients with a specific genetic profile stay cancer-free long ...
Lack of Insurance Keeps Many Americans From Best Cancer Meds | FOX 28 Spokane
FOX 28 Spokane· 4 days agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. New policies are...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Arizona Daily Sun· 4 days agoModerna and partner Merck & Co said on Monday their cancer vaccine in combination with blockbuster ...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 4 days agoThe company presented the latest results from its trial involving 157 people with advanced skin cancer at the annual meeting of the American Society of...
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024...
KOLR - KSFX Ozarks· 6 days agoTiumBio Co., Ltd. (Kosdaq: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable diseases, announced ...
Twist Bioscience develops potential cancer therapy antibody By Investing.com
Investing.com· 23 hours agoThe antibody targets the adenosine A2A receptor (A2AR), an immune checkpoint involved in tumor...